Kura Oncology (KURA) Tops Q4 EPS by 8c

Kura Oncology (NASDAQ: KURA) reported Q4 EPS of ($0.49), $0.08 better than the analyst estimate of ($0.57). Revenue for the quarter came in at $0 versus the consensus estimate of $0 .

For earnings history and earnings-related data on Kura Oncology (KURA) click here.

You May Also Be Interested In

• Activist investor presses Xerox to review financial services arm - Bloomberg
• Citi turns more bullish on trucking stocks
• BMO Capital Reiterates Outperform Rating on NVIDIA (NVDA)